Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Jul-01-23 | Apr-01-23 | Dec-31-22 | Oct-01-22 | Jul-02-22 | Apr-02-22 | Dec-31-21 | Oct-02-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Life Sciences Solutions | 11,084.0 | 11,913.0 | 13,532.0 | 14,635.0 | 15,394.0 | 15,659.0 | 15,631.0 | 15,849.0 |
| Analytical Instruments | 6,971.0 | 6,829.0 | 6,624.0 | 6,471.0 | 6,326.0 | 6,200.0 | 6,069.0 | 5,980.0 |
| Specialty Diagnostics | 4,397.0 | 4,389.0 | 4,763.0 | 5,095.0 | 5,392.0 | 5,526.0 | 5,659.0 | 6,179.0 |
| Other | 21,072.0 | 20,676.0 | 19,996.0 | 17,966.0 | 15,708.0 | 10,155.0 | 4,672.0 | 3,871.0 |
| Total revenues | 43,524.0 | 43,807.0 | 44,915.0 | 44,167.0 | 42,820.0 | 41,123.0 | 39,211.0 | 39,059.0 |
| Revenue growth [+] | 1.6% | 6.5% | 14.5% | 13.1% | 11.9% | 14.6% | 21.7% | 37.1% |
| Life Sciences Solutions | -28.0% | -23.9% | -13.4% | -7.7% | -1.0% | 7.3% | 28.5% | 64.4% |
| Analytical Instruments | 10.2% | 10.1% | 9.1% | 8.2% | 8.3% | 14.6% | 18.4% | 19.5% |
| Specialty Diagnostics | -18.5% | -20.6% | -15.8% | -17.5% | -13.7% | -7.9% | 5.9% | 43.2% |
| Other | -2.9% | | | | | | | |
| Cost of goods sold | 26,225.0 | 26,160.0 | 25,944.0 | 24,548.0 | 22,852.0 | 21,230.0 | 19,573.0 | 19,119.0 |
| Gross profit | 17,299.0 | 17,647.0 | 18,971.0 | 19,619.0 | 19,968.0 | 19,893.0 | 19,638.0 | 19,940.0 |
| Gross margin | 39.7% | 40.3% | 42.2% | 44.4% | 46.6% | 48.4% | 50.1% | 51.1% |
| Selling, general and administrative [+] | 8,771.0 | 8,835.0 | 8,993.0 | 8,972.0 | 8,768.0 | 8,458.0 | 8,007.0 | 7,806.0 |
| Sales and marketing | 6,472.0 | 6,536.0 | | 6,694.0 | 6,490.0 | 6,180.0 | | 5,729.0 |
| General and administrative | | | 2,299.0 | | | | 2,278.0 | |
| Research and development | 1,433.0 | 1,453.0 | 1,471.0 | 1,472.0 | 1,472.0 | 1,450.0 | 1,406.0 | 1,390.0 |
| Equity in earnings | -143.0 | -178.0 | -172.0 | -142.0 | -73.0 | -23.0 | | -7.0 |
| EBITDA [+] | 10,352.0 | 10,562.0 | 11,716.0 | 12,249.0 | 12,661.0 | 12,792.0 | 12,813.0 | 13,248.0 |
| EBITDA growth | -18.2% | -17.4% | -8.6% | -7.5% | -5.1% | 3.3% | 25.4% | 58.7% |
| EBITDA margin | 23.8% | 24.1% | 26.1% | 27.7% | 29.6% | 31.1% | 32.7% | 33.9% |
| Depreciation | 1,023.0 | 989.0 | 986.0 | 947.0 | 908.0 | 883.0 | 831.0 | 805.0 |
| EBITA | 9,329.0 | 9,573.0 | 10,730.0 | 11,302.0 | 11,753.0 | 11,909.0 | 11,982.0 | 12,443.0 |
| EBITA margin | 21.4% | 21.9% | 23.9% | 25.6% | 27.4% | 29.0% | 30.6% | 31.9% |
| Amortization of intangibles | 2,377.0 | 2,392.0 | 2,395.0 | 2,269.0 | 2,098.0 | 1,947.0 | 1,761.0 | 1,706.0 |
| EBIT [+] | 6,952.0 | 7,181.0 | 8,335.0 | 9,033.0 | 9,655.0 | 9,962.0 | 10,221.0 | 10,737.0 |
| EBIT growth | -28.0% | -27.9% | -18.5% | -15.9% | -11.3% | -0.5% | 29.5% | 77.4% |
| EBIT margin | 16.0% | 16.4% | 18.6% | 20.5% | 22.5% | 24.2% | 26.1% | 27.5% |
| Non-recurring items | 383.0 | 224.0 | 114.0 | 105.0 | 90.0 | 185.0 | 197.0 | 183.0 |
| Interest expense, net [+] | 526.0 | 490.0 | 454.0 | 485.0 | 499.0 | 498.0 | 493.0 | 477.0 |
| Interest expense | 1,068.0 | 890.0 | 726.0 | 618.0 | 573.0 | 547.0 | 536.0 | 521.0 |
| Interest income | 542.0 | 400.0 | 272.0 | 133.0 | 74.0 | 49.0 | 43.0 | 44.0 |
| Other income (expense), net [+] | 128.0 | 191.0 | 68.0 | -523.0 | -570.0 | -651.0 | -690.0 | -201.0 |
| Other | | 13.0 | -104.0 | -665.0 | -643.0 | -674.0 | -694.0 | -208.0 |
| Pre-tax income | 6,171.0 | 6,658.0 | 7,835.0 | 7,920.0 | 8,496.0 | 8,628.0 | 8,841.0 | 9,876.0 |
| Income taxes | 302.0 | 448.0 | 703.0 | 733.0 | 973.0 | 994.0 | 1,109.0 | 1,300.0 |
| Tax rate | 4.9% | 6.7% | 9.0% | 9.3% | 11.5% | 11.5% | 12.5% | 13.2% |
| Minority interest | 5.0 | 8.0 | 10.0 | 13.0 | 11.0 | 8.0 | 3.0 | 4.0 |
| Net income | 5,721.0 | 6,024.0 | 6,950.0 | 7,032.0 | 7,439.0 | 7,603.0 | 7,725.0 | 8,565.0 |
| Net margin | 13.1% | 13.8% | 15.5% | 15.9% | 17.4% | 18.5% | 19.7% | 21.9% |
| |
| Basic EPS [+] | $14.71 | $15.43 | $17.73 | $17.92 | $18.93 | $19.33 | $19.62 | $21.72 |
| Growth | -22.3% | -20.2% | -9.6% | -17.5% | -13.1% | -3.6% | 21.9% | 76.8% |
| Diluted EPS [+] | $14.62 | $15.34 | $17.62 | $17.79 | $18.80 | $19.19 | $19.47 | $21.56 |
| Growth | -22.2% | -20.1% | -9.5% | -17.5% | -13.0% | -3.6% | 21.9% | 76.8% |
| |
| Dividends per share [+] | $1.30 | $1.25 | $1.20 | $1.16 | $1.12 | $1.08 | $1.04 | $1.00 |
| Growth | 16.1% | 15.7% | 15.4% | 16.0% | 16.7% | 17.4% | 18.2% | 17.6% |
| |
| Shares outstanding (basic) [+] | 389.0 | 390.5 | 392.0 | 392.5 | 393.0 | 393.3 | 393.8 | 394.3 |
| Growth | -1.0% | -0.7% | -0.4% | -0.4% | -0.4% | -0.5% | -0.6% | -0.7% |
| Shares outstanding (diluted) [+] | 391.3 | 392.8 | 394.5 | 395.3 | 395.8 | 396.3 | 396.8 | 397.3 |
| Growth | -1.1% | -0.9% | -0.6% | -0.5% | -0.5% | -0.5% | -0.6% | -0.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|